Advertisement

Rheumatoid Arthritis-Associated Interstitial Lung Disease

Chapter
  • 642 Downloads
Part of the Respiratory Medicine book series (RM)

Abstract

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a frequent and clinically important extra-articular manifestation of RA. Although most patients with RA-ILD will experience disease progression over time, RA-ILD encompasses a wide range of disease severity. Early recognition of RA-ILD is essential to ensure adequate patient care. This chapter will review the epidemiology, clinical presentation, evaluation, diagnosis, and natural history of RA-ILD.

Keywords

Interstitial lung disease Rheumatoid arthritis Risk factors Symptoms Diagnosis Prognosis 

References

  1. 1.
    Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis. 2003;62(8):722–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583–91.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Olson AL, Swigris JJ, Sprunger DB, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372–8.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2010;35(6):1322–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Ellman P, Ball RE. Rheumatoid disease with joint and pulmonary manifestations. Br Med J. 1948;2(4583):816–20.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax. 2001;56(8):622–7.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med. 2008;168(2):159–66.CrossRefPubMedGoogle Scholar
  8. 8.
    Richman NC, Yazdany J, Graf J, Chernitskiy V, Imboden JB. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine. 2013;92(2):92–7.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Zrour SH, Touzi M, Bejia I, et al. Correlations between high-resolution computed tomography of the chest and clinical function in patients with rheumatoid arthritis. Prospective study in 75 patients. Joint Bone Spine. 2005;72(1):41–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Norton S, Koduri G, Nikiphorou E, Dixey J, Williams P, Young A. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology (Oxford). 2013;52(1):99–110.CrossRefGoogle Scholar
  11. 11.
    Zou YQ, Li YS, Ding XN, Ying ZH. The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China. Rheumatol Int. 2012;32(3):669–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis. 2003;62(9):897–900.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Mori S, Cho I, Koga Y, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol. 2008;35(8):1513–21.PubMedGoogle Scholar
  14. 14.
    Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):528–35.CrossRefPubMedGoogle Scholar
  15. 15.
    Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. Am J Med. 1973;54(4):445–52.CrossRefPubMedGoogle Scholar
  16. 16.
    Stack BH, Grant IW. Rheumatoid interstitial lung disease. Br J Dis Chest. 1965;59(4):202–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Padley SP, Hansell DM, Flower CD, Jennings P. Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol. 1991;44(4):222–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Chen J, Shi Y, Wang X, Huang H, Ascherman D. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol. 2013;2013:406927.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Carotti M, Salaffi F, Manganelli P, Salvolini L, Bichi Secchi E, De Berardinis S. The subclinical involvement of the lung in rheumatoid arthritis: evaluation by high-resolution computed tomography. Reumatismo. 2001;53(4):280–8.PubMedGoogle Scholar
  20. 20.
    Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E. Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis. 2007;66(11):1543–4.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Doyle TJ, Patel AS, Hatabu H, et al. Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med. 2015;191(12):1403–12.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med. 2012;106(11):1591–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics—a large multicentre UK study. Rheumatology (Oxford). 2014;53(9):1676–82.CrossRefGoogle Scholar
  24. 24.
    Weyand CM, Schmidt D, Wagner U, Goronzy JJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum. 1998;41(5):817–22.CrossRefPubMedGoogle Scholar
  25. 25.
    Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol. 2006;35(3):169–74.CrossRefPubMedGoogle Scholar
  26. 26.
    Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 1997;56(8):463–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis. 2014;73(8):1487–94.CrossRefPubMedGoogle Scholar
  28. 28.
    Mori S, Cho I, Koga Y, Sugimoto M. A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol. 2008;18(1):60–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Fischer A, Solomon JJ, du Bois RM, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med. 2012;106(7):1040–7.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Brannan HM, Good CA, Divertie MB, Baggenstoss AH. Pulmonary disease associated with rheumatoid arthritis. JAMA. 1964;189:914–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Akira M, Sakatani M, Hara H. Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr. 1999;23(6):941–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Nurmi HM, Purokivi MK, Karkkainen MS, Kettunen HP, Selander TA, Kaarteenaho RL. Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes. BMC Pulm Med. 2016;16(1):107.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Gizinski AM, Mascolo M, Loucks JL, et al. Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clin Rheumatol. 2009;28(5):611–3.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Zayeni H, Haji-Abbasi A, Foumani SA, et al. Pulmonary involvement in rheumatoid arthritis: a cross-sectional study in Iran. Lung India. 2016;33(1):49–52.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Wang JX, Du CG. A retrospective study of clinical characteristics of interstitial lung disease associated with rheumatoid arthritis in Chinese patients. Med Sci Monit. 2015;21:708–15.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mohd Noor N, Mohd Shahrir MS, Shahid MS, Abdul Manap R, Shahizon Azura AM, Azhar Shah S. Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease. Int J Rheum Dis. 2009;12(2):136–44.CrossRefPubMedGoogle Scholar
  37. 37.
    Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum. 1996;39(10):1711–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Hamblin MJ, Horton MR. Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulm Med. 2011;2011:872120.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Skare TL, Nakano I, Escuissiato DL, Batistetti R, Rodrigues Tde O, Silva MB. Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables. Rev Bras Reumatol. 2011;51(4):325–30. 336–327.CrossRefPubMedGoogle Scholar
  40. 40.
    Pappas DA, Giles JT, Connors G, Lechtzin N, Bathon JM, Danoff SK. Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study. Arthritis Res Ther. 2010;12(3):R104.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Doyle TJ, Dellaripa PF, Batra K, et al. Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis. Chest. 2014;146(1):41–50.CrossRefPubMedGoogle Scholar
  42. 42.
    Dawson JK, Fewins HE, Desmond J, Lynch MP, Graham DR. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis. 2002;61(6):517–21.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis. 2008;67(10):1488–92.CrossRefPubMedGoogle Scholar
  45. 45.
    Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38–46.CrossRefPubMedGoogle Scholar
  46. 46.
    Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–87.CrossRefPubMedGoogle Scholar
  47. 47.
    Chansakul T, Dellaripa PF, Doyle TJ, Madan R. Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications. Eur J Radiol. 2015;84(10):1981–91.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL. Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor alpha agents, a retrospective cohort study. Arthritis Res Ther. 2015;17:319.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Roubille C, Haraoui B. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2014;43(5):613–26.CrossRefPubMedGoogle Scholar
  50. 50.
    Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum. 2006;54(5):1435–9.CrossRefPubMedGoogle Scholar
  51. 51.
    Camus P, Kudoh S, Ebina M. Interstitial lung disease associated with drug therapy. Br J Cancer. 2004;91(Suppl 2):S18–23.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration. 2004;71(4):301–26.CrossRefPubMedGoogle Scholar
  53. 53.
    Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease. Clin Rheumatol. 2016;35(10):2585–9.CrossRefPubMedGoogle Scholar
  54. 54.
    Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232(1):81–91.CrossRefPubMedGoogle Scholar
  55. 55.
    Assayag D, Elicker BM, Urbania TH, et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology. 2014;270(2):583–8.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Biederer J, Schnabel A, Muhle C, Gross WL, Heller M, Reuter M. Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol. 2004;14(2):272–80.CrossRefPubMedGoogle Scholar
  57. 57.
    Perez T, Farre JM, Gosset P, et al. Subclinical alveolar inflammation in rheumatoid arthritis: superoxide anion, neutrophil chemotactic activity and fibronectin generation by alveolar macrophages. Eur Respir J. 1989;2(1):7–13.PubMedGoogle Scholar
  58. 58.
    Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest. 2005;127(6):2019–27.CrossRefPubMedGoogle Scholar
  59. 59.
    Solomon JJ, Ryu JH, Tazelaar HD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med. 2013;107(8):1247–52.CrossRefPubMedGoogle Scholar
  60. 60.
    Assayag D, Lee JS, King TE Jr. Rheumatoid arthritis associated interstitial lung disease: a review. Medicina. 2014;74(2):158–65.PubMedGoogle Scholar
  61. 61.
    Tsuchiya Y, Takayanagi N, Sugiura H, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J. 2011;37(6):1411–7.CrossRefPubMedGoogle Scholar
  62. 62.
    Song JW, Lee HK, Lee CK, et al. Clinical course and outcome of rheumatoid arthritis-related usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2013;30(2):103–12.PubMedGoogle Scholar
  63. 63.
    Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (Oxford). 2007;46(2):350–7.CrossRefGoogle Scholar
  64. 64.
    Suzuki A, Ohosone Y, Obana M, et al. Cause of death in 81 autopsied patients with rheumatoid arthritis. J Rheumatol. 1994;21(1):33–6.PubMedGoogle Scholar
  65. 65.
    Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(6):1530–42.CrossRefPubMedGoogle Scholar
  66. 66.
    Dixon WG, Hyrich KL, Watson KD, Lunt M, Symmons DP. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis. 2010;69(6):1086–91.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford). 2010;49(8):1483–9.CrossRefGoogle Scholar
  68. 68.
    Solomon JJ, Chung JH, Cosgrove GP, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47(2):588–96.CrossRefPubMedGoogle Scholar
  69. 69.
    Assayag D, Lubin M, Lee JS, King TE, Collard HR, Ryerson CJ. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology. 2014;19(4):493–500.CrossRefPubMedGoogle Scholar
  70. 70.
    Hozumi H, Nakamura Y, Johkoh T, et al. Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open. 2013;3(9):e003132.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Département de MédecineCentre Hospitalier de l’Université de MontréalMontréalCanada
  2. 2.Department of MedicineUniversity of Colorado DenverAuroraUSA

Personalised recommendations